Board Won’t Rehear Denial Of Institution Of Inter Partes Review
ALEXANDRIA, Va. — Efforts by Apotex Inc. and Apotex Corp. (Apotex, collectively) to persuade the Patent Trial and Appeal Board to revisit its 2018 decision denying institution of inter partes review...To view the full article, register now.
Already a subscriber? Click here to view full article